Omeros (OMER) Inventory (2014 - 2026)
Omeros (OMER) posted Inventory of $183000.0 for Q1 2026, down 74.3% sequentially from $712000.0 in Q3 2021.
Powered by 
Analysis
Omeros (OMER) Inventory (2014 - 2026) Analysis & Trends
Omeros has reported Inventory for 9 years, with the latest figure at $183000.0 in Q1 2026.
- Quarterly Inventory changed N/A year-over-year to $183000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183000.0 (changed N/A YoY) and the FY2020 annual result came in at $1.4 million, up 18.13% from the prior year.
- Inventory fell to $183000.0 in Q1 2026 per OMER's latest filing, from $712000.0 in the prior quarter.
- Over five years, Inventory peaked at $183000.0 in Q1 2026 and troughed at $183000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | 842,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 842,000.00 |
| Mar 31, 2026 | 183,000.00 |
| Sep 30, 2021 | 712,000.00 |
| Jun 30, 2021 | 978,000.00 |
| Mar 31, 2021 | 1.19 Mn |
| Dec 31, 2020 | 1.36 Mn |
| Sep 30, 2020 | 1.54 Mn |
| Jun 30, 2020 | 1.89 Mn |
| Mar 31, 2020 | 1.21 Mn |
| Dec 31, 2019 | 1.15 Mn |
| Sep 30, 2019 | 1.17 Mn |
| Jun 30, 2019 | 1.19 Mn |
| Mar 31, 2019 | 736,000.00 |
| Dec 31, 2018 | 88,000.00 |
| Sep 30, 2018 | 214,000.00 |
| Jun 30, 2018 | 235,000.00 |
| Mar 31, 2018 | 247,000.00 |
| Dec 31, 2017 | 443,000.00 |
| Sep 30, 2017 | 822,000.00 |
| Jun 30, 2017 | 905,000.00 |